Related Experiment Videos
Tau gene mutations and neurodegeneration
1Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, U.K.
Biochemical Society Symposium
|July 13, 2001
Summary
Genetic mutations in the tau gene cause neurodegeneration and dementia. These tau gene mutations lead to abnormal tau protein buildup, resulting in frontotemporal dementia with Parkinsonism and other neurological disorders.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Neurofibrillary lesions of tau protein are hallmarks of Alzheimer's disease and other neurodegenerative conditions.
- The correlation between tau pathology distribution and disease symptoms is well-established.
- Genetic links between tau protein dysfunction and neurodegeneration were previously lacking.
Purpose of the Study:
- To establish a genetic link between tau protein dysfunction and neurodegeneration.
- To investigate the role of tau gene mutations in frontotemporal dementia with Parkinsonism.
- To understand how tau gene mutations lead to pathological tau accumulation.
Main Methods:
- Analysis of tau gene mutations in patients with frontotemporal dementia with Parkinsonism.
- Examination of tau protein pathology in brain cells of affected individuals.
- Investigating the impact of specific tau mutations on tau protein function and assembly.
Main Results:
- Discovery of nearly 20 mutations in the tau gene associated with frontotemporal dementia with Parkinsonism.
- All examined cases with tau mutations exhibited abundant filamentous tau pathology.
- Mutations affect tau's microtubule interaction and promote tau filament assembly.
- Intronic and some coding mutations increase exon 10 splicing, leading to four-repeat tau isoform overexpression.
Conclusions:
- Tau protein dysfunction, driven by genetic mutations, can cause neurodegeneration and dementia.
- A normal ratio of three-repeat to four-repeat tau isoforms is crucial for preventing tau pathology.
- The location of tau gene mutations influences the resulting pathological heterogeneity.